Message #20 From:
NewsBot Date: October 19, 2006 06:27:00 AM
ZYNX News Zynex Medical's Two-Fold Increase in September Unit Orders Demonstrates Impact of New Sales Force
LITTLETON, Colo.--(BUSINESS WIRE)--Zynex Medical (OTCBB: ZYNX), a provider of pain management systems and
electrotherapy products for medical patients with functional disability,
has significantly increased the number of monthly unit orders since it
expanded its sales force in July and August 2006.
Zynex’s monthly unit orders increased to more
than 250 during August and more than 300 in September, from an average
of approximately 150 units during the first seven months of the year.
The company believes this increase in sales and rentals is directly
attributed to its recent addition of an experienced sales team skilled
in electrotherapy product sales.
“The hiring of additional sales
representatives was an important milestone for Zynex Medical,”
said Thomas Sandgaard, President and Chief Executive Officer. “We
are pleased, but not surprised, that this expanded team is beginning to
make a tremendous impact on our sales and market penetration.”
Zynex has not yet finalized its results for the third quarter of 2006,
including the impact of increased sales and rentals. Zynex will state
these results in the Form 10-QSB for the quarter.
Zynex Medical
Zynex Medical Holdings, Inc. (founded in 1996) engineers, manufactures,
markets and sells its own design of electrotherapy medical devices in
two distinct markets: standard digital electrotherapy products for pain
relief and pain management; and the NeuroMove(TM) for stroke and spinal
cord injury (SCI) rehabilitation. Zynex's product lines are fully
developed, FDA-cleared, commercially sold, and have been developed to
uphold the Company's mission of improving the quality of life for
patients suffering from impaired mobility due to stroke, spinal cord
injury, or debilitating and chronic pain.
Safe Harbor Statement
Certain statements in this release are "forward-looking" and as such are
subject to numerous risks and uncertainties. Actual results may vary
significantly from the results expressed or implied in such statements.
Factors that could cause actual results to materially differ from
forward-looking statements include, but are not limited to, risks and
delays associated with product development, risk of market acceptance of
products, technology or product obsolescence, competitive risks,
reliance on manufacturing partners, dependence on reimbursement from
insurance companies, additional capital needs and other risks described
in our Form 10-KSB for the year ended December 31, 2005.
